Health Canada Denies Healthcare Practitioners’ Section 56 Exemptions—After Granting Them To A Group In 2020 Feb 2, 2022
Mydecine Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001 Seamless Phase 2/3 Smoking… Feb 1, 2022
